Lataa...
Cutaneous Side Effects of BRAF Inhibitors in Advanced Melanoma: Review of the Literature
The incidence of melanoma has recently been increasing. BRAF mutations have been found in 40–60% of melanomas. The increased activity of BRAF V600E leads to the activation of downstream signaling through the mitogen-activated protein kinase (MAPK) pathway, which plays a key role as a regulator of ce...
Tallennettuna:
| Julkaisussa: | Dermatol Res Pract |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Publishing Corporation
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4794559/ https://ncbi.nlm.nih.gov/pubmed/27042173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5361569 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|